硕世生物：猴痘病毒核酸检测试剂盒列入WHO应急使用清单

Core Viewpoint - The company’s monkeypox virus nucleic acid testing kit (fluorescent PCR method) has been included in the WHO Emergency Use Listing as of December 3, indicating recognition from WHO and providing a basis for procurement, which may facilitate the product's promotion and sales in overseas markets [1] Group 1 - The inclusion in the WHO list has a procurement period of one year unless special circumstances arise [1] - The recognition by WHO can serve as a reference for potential buyers, enhancing the product's credibility in international markets [1] - Actual sales are subject to various factors including overseas policies, demand, and competition, leading to uncertainty in sales scale [1] Group 2 - The company is currently unable to predict the impact of this development on future performance [1]